TMCnet News
Realbotix Provides Update on Nasdaq Listing TimelineRealbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) ("Realbotix" or the "Parent Company"), a manufacturer of humanoid robots and AI systems, announces that it has extended the outside date for completion of its all-stock merger transaction between Realbotix LLC ("RealLLC" or the "Subsidiary"), a wholly owned subsidiary of Realbotix, and Onconetix, Inc. (NASDAQ: ONCO) ("ONCO") to March 31, 2027. "We appreciate shareholder patience as we move closer to completing the merger with Onconetix," said Andrew Kiguel, CEO of Realbotix. "The extension demonstrates the mutual commitment to complete this transaction, and the benefits to our mutual shareholders. Onconetix has already advanced Realbotix LLC $3 million to show their commitment to completing this transaction as quickly as possible." The proposed transaction will result in the robotics and AI business of RealLLC to be listed on Nasdaq, with the Parent Company (Realbotix) maintaining a 75-95% ownership stake. No action is required by existing Realbotix shareholders as there are no changes to the structure of the Parent Company. The transaction is now expected to close before the end of the first calendar quarter of 2027. Under the Amendment, the outside date under the Share Exchange Agreement has been extended from November 30, 2026, to March 31, 2027. The Amendment also removes the minimum net cash closing condition from the Share Exchange Agreement, allowing the transaction to proceed to closing without ONCO being required to satisfy such condition. Benefits to Realbotix Shareholders:
RealLLC is a Nevada based subsidiary of Realbotix, the Parent Company. RealLLC designs and manufactures AI-powered humanoid robots for use in consumer-facing social roles such as customer service, healthcare, education, hospitality, and entertainment. RealLLC's operations include an engineering division, AI software division, robotics patents, and intellectual property.
About Realbotix
Realbotix will be exhibiting at the Humanoid Summit in Silicon Valley on December 1-2, 2026, and CES 2027 in Las Vegas on January 6-9, 2027. Attendees of the events will be able to view live demonstrations and presentations of the Realbotix Series 1 humanoid robots and AI.
Realbotix.com: Product site
Keep up to date with Realbotix developments by joining our online communities on X, LinkedIn, and YouTube. Follow Aria, our humanoid robot, on X , Instagram and TikTok.
About Onconetix, Inc.
Forward-Looking Statements
These forward-looking statements are based on management's current opinions and expectations and are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by such statements. Readers are cautioned not to place undue reliance on forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. All forward-looking statements are subject to the risks and uncertainties detailed in the Company's continuous disclosure filings available at www.sedarplus.ca. The Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261109430619/en/ |

